Skip to Content

Tilray Inc TLRY

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

All Cannabis Stocks Rally From Senate Results, but Actual Economic Exposure Differs Widely

Analyst Note

| Kristoffer Inton |

On Jan. 5, Georgia held runoff elections for its two Senate seats. Major news outlets have called the election for the Democrats, ousting both Republican incumbents and leaving the Senate evenly split. Under a 50-50 split, Vice President-elect Kamala Harris would cast the tiebreaking vote, effectively giving control to Democrats. With control of the White House and both chambers of Congress, President-elect Joe Biden has received an accommodative path for his agenda.

Read Full Analysis

Company Profile

Business Description

Tilray, headquartered in Nanaimo, Canada, cultivates and sells medical and recreational cannabis through a portfolio of brands that include Canaca, Dubon, and Manitoba Harvest. The bulk of Tilray’s sales are in Canada, but the company also sells CBD Products in the U.S. and exports medical cannabis globally from its production facilities in Canada and Portugal. Tilray also has a joint venture partnership with AB InBev to develop cannabis-infused drinks.

Contact
1100 Maughan Road
Nanaimo, BC, V9X IJ2
T +1 844 845-7291
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Sep 30, 2020
Fiscal Year End Dec 31, 2020
Stock Type Distressed
Employees 1,646